Finding rare cells in blood, &
Wider reach for leukemia/lymphoma diagnosis
The sophisticated laboratory system known as the flow cytometer has been instrumental in sub-typing leukemia and lymphoma, personalizing treatment, and driving up adult survival rates from 15% to almost 80%; and for children even higher. But, these are not worldwide statistics, and leukemia/lymphoma is a uniform global problem, where there are 600,000 new cases each year. Most of these cases face survival rates of only 5% to 20%. Many have reasoned that the complex flow cytometer cannot be re-assigned to these areas and a new technical solution is needed. This project team is creating an optical technique that can be deployed on much simpler systems (such as the system developed in the initial project) to achieve this solution.
[/vc_column][vc_column fade_animation=”in” fade_animation_offset=”45px” width=”1/3″]

Contact
Project sector
In Vitro diagnostics, Medical devices
Project status
M+Visión project: Jan 2012 – Jun 2014
On exit from M+Visión: Seeking support
M+Visión follow on project: Oct 2014 – Sep 2015
Fellows
Shivang Dave, Germán González Serrano (original team)
Luca Giancardo (joined 2013)
Jason Tucker-Schwartz, Judith Birkenfeld (joined 2014)
Collaborators
Mertxe Mercedes Alonso, Maria Isabel Pacheco, David Omos
Centro Nacional de Investigaciones Oncológicas (CNIO)
Susana Burromeo, Norberto Malpica, Alfonso de Lara-Rubio, Esteban Pardo
Universidad Rey Juan Carlos (URJC)
Conor Evans, Tim Padera
Massachusetts General Hospital (MGH)
Peter Hansen
Point Care Technologies, Inc
Media and updates
On October 23, 2014, Team Cell pitched at a FENIN (Federación Española de Empresas de Tecnología Sanitaria,) ‘In Vitro Diagnostics” event in Barcelona:
On November 15, 2012, Team Cell won the top prize in the offline business category in the IE Business School Venture Days business plan competition. As the winning team (which includes collaborators from IE), Team Cell wins venture funding, expert counseling, and incubator space in Madrid.
For more information, please visit the Venture Days page +
[/vc_column][/vc_row]